Advertisement

Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis

Published:March 17, 2011DOI:https://doi.org/10.1016/j.ajog.2011.03.021

      Objective

      The purpose of this study was to examine which maternal and neonatal complications are associated with polycystic ovary syndrome (PCOS) in pregnant women.

      Study Design

      The studies that were included compared pregnancy outcomes between women with PCOS and those without diagnosed PCOS. Our primary outcomes included gestational diabetes mellitus, pregnancy-induced hypertension, and preeclampsia. Secondary outcomes included cesarean delivery rates, operative vaginal delivery rates, preterm delivery, small-for-gestational-age (SGA) infants and large-for-gestational-age infants.

      Results

      We found that PCOS in pregnancy was associated with higher rates of gestational diabetes mellitus, pregnancy-induced hypertension, preeclampsia, preterm delivery, cesarean delivery, operative vaginal delivery, SGA, and large-for-gestational age. Only gestational diabetes mellitus, pregnancy-induced hypertension, preeclampsia, preterm delivery, and SGA infants were found to be statistically significant.

      Conclusion

      This metaanalysis confirms the higher association of pregnancy complications and PCOS compared with patients who do not have PCOS. Additionally, there may be a stronger association between PCOS and hypertensive disorders than has been shown previously.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tang T.
        • Lord J.M.
        • Norman R.J.
        • Yasmin E.
        • Balen A.H.
        Insulin-sensitizing drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhea and subfertility.
        Cochrane Database Syst Rev. 2009; (CD003053)
        • American College of Obstetricians and Gynecologists
        ACOG practice bulletin no. 108: polycystic ovary syndrome.
        Obstet Gynecol. 2009; 114: 936-949
        • Azziz R.
        • Ehrmann D.
        • Legro R.S.
        • et al.
        Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double-blond, placebo-controlled trial.
        J Clin Endocrinol Metab. 2001; 86: 1626-1632
        • Lord J.M.
        • Flight I.H.
        • Norman R.J.
        Metformin in polycystic ovary syndrome: systematic review and meta-analysis.
        BMJ. 2003; 327: 951-953
        • Heijnen E.
        • Eijkemans M.
        • Hughes E.
        • Laven J.
        • Macklon N.
        • Fauser B.
        A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
        Hum Reprod Update. 2006; 12: 13-21
        • Yogev Y.
        • Ben-Haroush A.
        • Chen R.
        • et al.
        Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women.
        Am J Obstet Gynecol. 2004; 191: 949
        • Ryan E.
        Hormones and insulin resistance in pregnancy.
        Lancet. 2003; 362: 1777
        • Jensen R.B.
        • Chellakooty M.
        • Vielwerth S.
        • et al.
        Intrauterine growth retardation and consequences for endocrine and cardiovascular disease in adult life: does insulin-like growth factor-1 play a role?.
        Horm Res. 2003; 60: 136-148
        • Boomsma C.M.
        • Eijkemans M.J.C.
        • Huges E.G.
        • et al.
        A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.
        Hum Reprod Update. 2006; 12: 673-683
        • Li G.
        • Fan L.
        • Zhang L.
        • et al.
        Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome.
        J Perinat Med. 2010; 38: 141-146
        • Azziz R.
        • Carmina E.
        • Dewailly D.
        • et al.
        The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: the complete task force report.
        Fertil Steril. 2009; 91: 456-488
        • Toulis K.A.
        • Goulis D.G.
        • Kolibianakis E.M.
        • et al.
        Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis.
        Fertil Steril. 2009; 92: 667-677
        • Stroup D.F.
        • Berlin J.A.
        • Morton S.C.
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • Altieri P.
        • Gambineri A.
        • Prontera O.
        • et al.
        Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes.
        Eur J Obstet Gynecol Reprod Biol. 2010; 149: 31-36
        • Hu S.
        • Lenoard A.
        • Seifalian A.
        • Hardiman P.
        Vascular dysfunction during pregnancy in women with polycystic ovary syndrome.
        Hum Reprod. 2007; 22: 1532-1539
        • Li G.
        • Fan L.
        • Zhang L.
        • Zhang W.
        • Huang X.
        Metabolic parameters and perinatal outcomes of gestational diabetes in women with polycystic ovary syndrome.
        J Perinat Med. 2010; 38: 141-146
        • Maliqueo M.
        • Echiburú B.
        • Crisosto N.
        • et al.
        Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome.
        Fertil Steril. 2009; 92: 277-282
        • Palomba S.
        • Falbo A.
        • Russo T.
        • Tolino A.
        • Orio F.
        • Zullo F.
        Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes.
        Fertil Steril. 2010; 94: 1805-1811
        • Diamant Y.Z.
        • Rimon E.
        • Evron S.
        High incidence of preeclamptic toxemia in patients with polycystic ovarian disease.
        Eur J Obstet Gynecol Reprod Biol. 1982; 14: 199-204
        • Levran J.S.
        • Imani B.
        • Eijkemans M.J.
        • Fauser B.C.
        New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
        Obstet Gynecol Surv. 2002; 57: 755-767
        • Wortsman J.
        • de Angeles S.
        • Futterweit W.
        • Singh K.B.
        • Kaufmann R.C.
        Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome.
        J Reprod Med. 1991; 36: 659-661
        • Cardenas M.
        • Coulson C.C.
        • Legro R.S.
        Infertile PCOS women do not have an increased risk for gestational diabetes or macrosomia [abstract].
        Hum Reprod Update. 2006; 12: 673-683
        • Urman B.
        • Sarac E.
        • Dogan L.
        • Gurgan T.
        Pregnancy in infertile PCOD patients, complications and outcome.
        J Reprod Med. 1997; 42: 501-505
        • Fridstrom M.
        • Nisell H.
        • Sjoblom P.
        • Hillensjo T.
        Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?.
        Hypertens Pregnancy. 1999; 18: 73-80
        • Radon P.A.
        • McMahon M.J.
        • Meyer W.R.
        Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.
        Obstet Gynecol. 1999; 94: 194-197
        • Kashyap S.
        • Claman P.
        Polycystic ovary disease and the risk of pregnancy-induced hypertension.
        J Reprod Med. 2000; 45: 991-994
        • Vollenhoven B.
        • Clark S.
        • Kovacs G.
        • Burger H.
        • Healy D.
        Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins.
        Aust N Z J Obstet Gynaecol. 2000; 40: 54-58
        • Mikola M.
        • Hiilesmaa V.
        • Halttunen M.
        • Suhonen L.
        • Tiitinen A.
        Obstetric outcome in women with polycystic ovarian syndrome.
        Hum Reprod. 2001; 16: 226-229
        • Bjercke S.
        • Dale P.O.
        • Tanbo T.
        • Storeng R.
        • Ertzeid G.
        • Abyholm T.
        Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.
        Gynecol Obstet Invest. 2002; 54: 94-98
        • Haakova L.
        • Cibula D.
        • Rezabek K.
        • Hill M.
        • Fanta M.
        • Zivny J.
        Pregnancy outcome in women with PCOS and in controls matched by age and weight.
        Hum Reprod. 2003; 18: 1438-1441
        • Turhan N.O.
        • Seçkin N.C.
        • Aybar F.
        • Inegöl I.
        Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients.
        Int J Gynaecol Obstet. 2003; 81: 163-168
        • Weerakiet S.
        • Srisombut C.
        • Rojanasakul A.
        • Panburana P.
        • Thakkinstian A.
        • Herabutya Y.
        Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome.
        Gynecol Endocrinol. 2004; 19: 134-140
        • Sir-Petermann T.
        • Hitchsfeld C.
        • Maliqueo M.
        • et al.
        Birth weight in offspring of mothers with polycystic ovarian syndrome.
        Hum Reprod. 2005; 20: 2122-2126
        • Lesser K.B.
        • Garcia F.A.
        Association between polycystic ovary syndrome and glucose intolerance during pregnancy.
        J Matern Fetal Med. 1997; 6: 303-307
        • Lo J.C.
        • Feigenbaum S.L.
        • Yang J.
        • Pressman A.R.
        • Selby J.V.
        • Go A.
        Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2006; 91: 1357-1363
        • Sir-Petermann T.
        • Echiburú B.
        • Maliqueo M.M.
        • et al.
        Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome.
        Hum Reprod. 2007; 22: 1830-1836